Concept
Nuclear magnetic resonance spectroscopy
Related people (339)
Cristina Ramona Cudalbu
Cristina Cudalbu obtained her Bachelors of Science degree in Medical Physics in 2002 and Masters of Science degree in Biophysics and Medical Physics in 2003, both from University Babes-Bolyai, Cluj-Napoca, Romania. In 2006 she obtained her PhD degree in Localized Proton MRS and time domain quantification of cerebral metabolites at 7T and 4.7T at University Lyon 1, RMN Laboratory, Villeurbanne, France.In 2007, she joined, as a Scientist, the Laboratory for Functional and Metabolic Imaging at EPFL, where she implemented new acquisition and quantification techniques for in vivo nitrogen, proton and carbon MRS for preclinical studies. Starting 2012, Cristina Cudalbu was appointed as Research Staff Scientist and 9.4T MRI Operational Manager at Centre d’Imagerie Biomédicale (CIBM) at EPFL. She is now developing new research lines at CIBM, being oriented towards new acquisition and quantification techniques for in vivo proton, phosphorous, carbon, nitrogen MRS and fast MRSI, diffusion weighted spectroscopy and brain macromolecules quantification. She is now applying these developments on chronic hepatic encephalopathy, a research area that she developed at CIBM (https://actu.epfl.ch/news/when-liver-disease-affects-the-brain/), and on different collaborative projects with researchers from the five partner institutions of CIBM.
Jean-Philippe Ansermet
Jean-Philippe Ansermet was born March 1, 1957 in Lausanne (legal origin Vaumarcus, NE). He obtained a diploma as physics engineer of EPFL in 1980. He went on to get a PhD from the University of Illinois at Urbana-Champaign where, from 1985 to 1987, he persued as post-doc with Prof. Slichter his research on catalysis by solid state NMR studies of molecules bound to the surface of catalysts. From 1987 to 1992 he worked at the materials research center of Ciba-Geigy, on polymers for microelectronics, composites, dielectrics and organic charge transfer complexes. In March 1992, as professor of experimental physics, he developed a laboratory on the theme of nanostructured materials and turned full professor in 1995. Since 1992, he teaches classical mechanics, first to future engineering students, since 2004 to physics majors. Since 2000, he teaches thermodynamics also, to the same group of students. He offers a graduate course in spintronics, and another on spin dynamics. His research activities concern the fabrication and properties of magnetic nanostructures produced by electrodeposition. His involvement since the early days of spintronics have allowed him to gain recognition for his work on giant magnetoresistance (CPP-GMR), magnetic relaxation of single nanostructures, and was among the leading groups demonstrating magnetization reversal by spin-polarized currents. Furthermore, his group uses nuclear magnetic resonance , on the one hand as means of investigation of surfaces and electrodes, on the other hand, as a local probe of the electronic properties of complex ferromagnetic oxides.
Mor-Miri Mishkovsky
I am a chemist, graduated Cum Laude in 2002 from Tel Aviv University in Israel. I obtained a PhD in Physical Chemistry from the Weizmann Institute of Science in Israel on the development of new technology for rapid detection of nuclear magnetic resonance (NMR) spectroscopic data aiming at reducing the measurement time from hours to a fraction of second with Prof. Lucio Frydman. My thesis “Methodological Developments in Ultrafast Multidimensional NMR” granted me the Auto Swartz excellence award in 2007. Since 2009 I am working with the Laboratory of Functional and Metabolic Imaging at the École Polytechnique Fédérale de Lausanne (EPFL), Switzerland, on the development of hyperpolarized (HP) magnetic resonance spectroscopy (MRS) methodologies for monitoring biochemical processes in real-time.My research is focused on the development of Magnetic Resonance (MR) Molecular Imaging by dissolution dynamic nuclear polarization (dDNP). HP agents to interrogate biochemical processes in real-time are applied in vivo in the healthy brain and disease models, aiming at improving our understanding of cerebral function and metabolism toward better clinical diagnostics and therapy.